413 related articles for article (PubMed ID: 9610864)
1. Melanoma-cell toxicity of cystemustine combined with O6-benzyl-N2-acetylguanosine.
Buchdahl C; Rolhion C; Glasser AL; Debiton E; Mounetou E; Madelmont JC; Laval F
Melanoma Res; 1998 Apr; 8(2):123-30. PubMed ID: 9610864
[TBL] [Abstract][Full Text] [Related]
2. Enhancement by O6-benzyl-N2-acetylguanosine of N'-[2-chloroethyl]-N-[2-(methylsulphonyl)ethyl]-N'-nitrosourea therapeutic index on nude mice bearing resistant human melanoma.
Debiton E; Cussac-Buchdhal C; Mounetou E; Rapp M; Dupuy JM; Maurizis JC; Veyre A; Madelmont JC
Br J Cancer; 1997; 76(9):1157-62. PubMed ID: 9365163
[TBL] [Abstract][Full Text] [Related]
3. Enhancement by O6-benzyl-N-acetylguanosine derivatives of chloroethylnitrosourea antitumor action in chloroethylnitrosourea-resistant human malignant melanocytes.
Cussac C; Rapp M; Mounetou E; Madelmont JC; Maurizis JC; Godeneche D; Dupuy JM; Sauzieres J; Baudry JP; Veyre A
J Pharmacol Exp Ther; 1994 Dec; 271(3):1353-8. PubMed ID: 7996446
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of O6-alkylguanine-DNA alkyltransferase by O6-benzyl-N2-acetylguanosine increases chloroethylnitrosourea-induced apoptosis in Mer+ human melanoma cells.
Debiton E; Glasser AL; Marchenay C; Rolhion C; Maurizis JC; Madelmont JC
Melanoma Res; 2002 Oct; 12(5):417-27. PubMed ID: 12394182
[TBL] [Abstract][Full Text] [Related]
5. Disposition and metabolism of O6-alkylguanine-DNA alkyltransferase inhibitor in nude mice bearing human melanoma.
Cussac C; Mounetou E; Rapp M; Madelmont JC; Maurizis JC; Labarre P; Chollet P; Chabard JL; Godeneche D; Baudry JP
Drug Metab Dispos; 1994; 22(4):637-42. PubMed ID: 7956741
[TBL] [Abstract][Full Text] [Related]
6. Retroviral-mediated expression of the P140A, but not P140A/G156A, mutant form of O6-methylguanine DNA methyltransferase protects hematopoietic cells against O6-benzylguanine sensitization to chloroethylnitrosourea treatment.
Maze R; Kurpad C; Pegg AE; Erickson LC; Williams DA
J Pharmacol Exp Ther; 1999 Sep; 290(3):1467-74. PubMed ID: 10454526
[TBL] [Abstract][Full Text] [Related]
7. G2 accumulation and melanin overproduction in malignant melanocytes treated with a new nitrosourea.
Buchdahl C; Papon J; Communal Y; Bourges M; Madelmont JC
Melanoma Res; 1998 Dec; 8(6):517-27. PubMed ID: 9918414
[TBL] [Abstract][Full Text] [Related]
8. A new O6-alkylguanine-DNA alkyltransferase inhibitor associated with a nitrosourea (cystemustine) validates a strategy of melanoma-targeted therapy in murine B16 and human-resistant M4Beu melanoma xenograft models.
Rapp M; Maurizis JC; Papon J; Labarre P; Wu TD; Croisy A; Guerquin-Kern JL; Madelmont JC; Mounetou E
J Pharmacol Exp Ther; 2008 Jul; 326(1):171-7. PubMed ID: 18411412
[TBL] [Abstract][Full Text] [Related]
9. DNA damage induced by a new 2-chloroethyl nitrosourea on malignant melanoma cells.
Godeneche D; Rapp M; Thierry A; Laval F; Madelmont JC; Chollet P; Veyre A
Cancer Res; 1990 Sep; 50(18):5898-903. PubMed ID: 2393861
[TBL] [Abstract][Full Text] [Related]
10. O6-methylguanine-DNA methyltransferase (MGMT) transfectants of a 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-sensitive colon cancer cell line selectively repopulate heterogenous MGMT+/MGMT- xenografts after BCNU and O6-benzylguanine plus BCNU.
Phillips WP; Willson JK; Markowitz SD; Zborowska E; Zaidi NH; Liu L; Gordon NH; Gerson SL
Cancer Res; 1997 Nov; 57(21):4817-23. PubMed ID: 9354444
[TBL] [Abstract][Full Text] [Related]
11. O6-(alkyl/aralkyl)guanosine and 2'-deoxyguanosine derivatives: synthesis and ability to enhance chloroethylnitrosourea antitumor action.
Mounetou E; Debiton E; Buchdahl C; Gardette D; Gramain JC; Maurizis JC; Veyre A; Madelmont JC
J Med Chem; 1997 Aug; 40(18):2902-9. PubMed ID: 9288172
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, DNA damage, and apoptosis induced by new fotemustine analogs on human melanoma cells in relation to O6-methylguanine DNA-methyltransferase expression.
Passagne I; Evrard A; Winum JY; Depeille P; Cuq P; Montero JL; Cupissol D; Vian L
J Pharmacol Exp Ther; 2003 Nov; 307(2):816-23. PubMed ID: 12970393
[TBL] [Abstract][Full Text] [Related]
13. O(6)-methylguanine DNA-methyltransferase (MGMT) overexpression in melanoma cells induces resistance to nitrosoureas and temozolomide but sensitizes to mitomycin C.
Passagne I; Evrard A; Depeille P; Cuq P; Cupissol D; Vian L
Toxicol Appl Pharmacol; 2006 Mar; 211(2):97-105. PubMed ID: 16039682
[TBL] [Abstract][Full Text] [Related]
14. Cystemustine induces redifferentiation of primary tumors and confers protection against secondary tumor growth in a melanoma murine model.
Demidem A; Morvan D; Papon J; De Latour M; Madelmont JC
Cancer Res; 2001 Mar; 61(5):2294-300. PubMed ID: 11280801
[TBL] [Abstract][Full Text] [Related]
15. Differential inactivation of O6-methylguanine-DNA methyltransferase activity by O6-arylmethylguanines.
Mineura K; Fukuchi M; Kowada M; Terashima I; Kohda K
Int J Cancer; 1995 Sep; 63(1):148-51. PubMed ID: 7558444
[TBL] [Abstract][Full Text] [Related]
16. Acquired resistance of melanoma cells to the antineoplastic agent fotemustine is caused by reactivation of the DNA repair gene MGMT.
Christmann M; Pick M; Lage H; Schadendorf D; Kaina B
Int J Cancer; 2001 Apr; 92(1):123-9. PubMed ID: 11279615
[TBL] [Abstract][Full Text] [Related]
17. Extended depletion of O6-methylguanine-DNA methyltransferase activity following O6-benzyl-2'-deoxyguanosine or O6-benzylguanine combined with streptozotocin treatment enhances 1,3-bis(2-chloroethyl)-1-nitrosourea cytotoxicity.
Marathi UK; Dolan ME; Erickson LC
Cancer Res; 1994 Aug; 54(16):4371-5. PubMed ID: 8044784
[TBL] [Abstract][Full Text] [Related]
18. [Study on potentiation of nitrosourea-cytotoxicity by DNA repair enzyme inhibitors in human brain tumor cells].
Fukuchi M; Mineura K; Kowada M; Terashima I; Kohda K
No To Shinkei; 1997 Jun; 49(6):521-8. PubMed ID: 9198092
[TBL] [Abstract][Full Text] [Related]
19. Role of O6-methylguanine-DNA methyltransferase in the resistance of pancreatic tumors to DNA alkylating agents.
Kokkinakis DM; Ahmed MM; Delgado R; Fruitwala MM; Mohiuddin M; Albores-Saavedra J
Cancer Res; 1997 Dec; 57(23):5360-8. PubMed ID: 9393761
[TBL] [Abstract][Full Text] [Related]
20. O6-methylguanine-DNA methyltransferase, O6-benzylguanine, and resistance to clinical alkylators in pediatric primary brain tumor cell lines.
Bobola MS; Silber JR; Ellenbogen RG; Geyer JR; Blank A; Goff RD
Clin Cancer Res; 2005 Apr; 11(7):2747-55. PubMed ID: 15814657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
